Villarrubia R, Oyagüez I, Álvarez MT, Mingot ME, Parra R, Casado MA
Cost analysis of bypassing agent prophylaxis treatment versus on-demand therapy in hemophilia a with inhibitor in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Gros B, Soto J, Casado MA
Future costs inclusion in published economic evaluations: What is the current situation?
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Álvarez-Sabín J, Masjuan J, Torres C, Mar J, Oliva J, González-Rojas N
Health-related quality of life in patients along first year poststroke in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Morote J, Cozar JM, Durán I, Gómez F, León L, Maroto P, Miñana B, Solsona E, Oyagüez I, Casado MA, Roldán C, Gutierrez L, Hechmati G
Cost assessment of metastatic and non-metastatic castration-resistante prostate cancer patient-management in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Torres C, Betoret I, Sabater E, Riera M, Casado MA, Figueras M
Cost-effectiveness analysis of glycopyrronium bromide in the treatment of chronic obstructive pulmonary disease in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Ariza-Ariza R, Van Walsem A, Canal C, Roldán C, Betegón L, Oyagüez I, Janssen K